Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis
- 19 July 2004
- Vol. 16 (8) , 520-525
- https://doi.org/10.1002/chir.20071
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Therapy for neurocysticercosisExpert Review of Neurotherapeutics, 2004
- Current Consensus Guidelines for Treatment of NeurocysticercosisClinical Microbiology Reviews, 2002
- Relative contribution of cytochromes P‐450 and flavin‐containing monoxygenases to the metabolism of albendazole by human liver microsomesBritish Journal of Clinical Pharmacology, 2000
- Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosisChirality, 1999
- Small intestinal sulphoxidation of AlbendazoleXenobiotica, 1995
- Clinical Pharmacokinetics of Albendazole in Patients with Brain CysticercosisThe Journal of Clinical Pharmacology, 1992
- Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattleResearch in Veterinary Science, 1991
- Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and ratsXenobiotica, 1991
- Albendazole kinetics in patients with echinococcosis: Delayed absorption and impaired elimination in cholestasisEuropean Journal of Clinical Pharmacology, 1990
- Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and ratsChirality, 1989